Sensorion reports its 2019 first half results - Signature of a framework agreement with Institut Pasteur in gene therapy - Financial position strengthened with the issuance of a €20m mandatory convertible bond. pdfRead

Pipeline

20190603 pipeline

Enregistrer

Patient center

Corporate presentation

Next events